Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
0.356
+0.008 (2.30%)
At close: Nov 22, 2024, 4:00 PM
0.362
+0.006 (1.63%)
After-hours: Nov 22, 2024, 6:58 PM EST
Cyclacel Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 2.98 | 3.38 | 18.35 | 36.56 | 33.41 | 11.89 | Upgrade
|
Cash & Short-Term Investments | 2.98 | 3.38 | 18.35 | 36.56 | 33.41 | 11.89 | Upgrade
|
Cash Growth | -49.83% | -81.59% | -49.82% | 9.44% | 181.08% | -32.10% | Upgrade
|
Other Receivables | - | 2.93 | 4.66 | 3.73 | 1.31 | 1.33 | Upgrade
|
Receivables | - | 2.93 | 4.66 | 3.73 | 1.31 | 1.33 | Upgrade
|
Prepaid Expenses | 1.93 | 0.79 | 0.98 | 0.58 | 0.68 | 0.7 | Upgrade
|
Other Current Assets | - | 0.34 | 0.43 | 0.08 | 0.07 | 0.1 | Upgrade
|
Total Current Assets | 4.91 | 7.44 | 24.41 | 40.94 | 35.47 | 14.02 | Upgrade
|
Property, Plant & Equipment | 0.06 | 0.1 | 0.17 | 0.09 | 1.33 | 1.29 | Upgrade
|
Other Long-Term Assets | 0.41 | 1.26 | 3.47 | 2.1 | - | - | Upgrade
|
Total Assets | 5.38 | 8.81 | 28.05 | 43.14 | 36.8 | 15.31 | Upgrade
|
Accounts Payable | 4.13 | 3.54 | 2.56 | 2.12 | 0.51 | 0.89 | Upgrade
|
Accrued Expenses | 2.23 | 4.24 | 4.62 | 3.04 | 1.11 | 0.85 | Upgrade
|
Other Current Liabilities | - | 0.38 | 0.33 | 0.26 | 0.87 | 0.68 | Upgrade
|
Total Current Liabilities | 6.35 | 8.16 | 7.51 | 5.41 | 2.49 | 2.42 | Upgrade
|
Long-Term Leases | - | 0.04 | 0.11 | 0.03 | 1.06 | 1.19 | Upgrade
|
Other Long-Term Liabilities | - | - | 4.49 | - | - | - | Upgrade
|
Total Liabilities | 6.35 | 8.2 | 12.11 | 5.44 | 3.54 | 3.61 | Upgrade
|
Common Stock | -0.97 | 0 | 0 | 0.01 | 0.01 | 0 | Upgrade
|
Additional Paid-In Capital | - | 429.8 | 422.98 | 422.96 | 400.07 | 370.14 | Upgrade
|
Retained Earnings | - | -428.28 | -405.73 | -384.53 | -366.07 | -357.63 | Upgrade
|
Comprehensive Income & Other | - | -0.91 | -1.32 | -0.75 | -0.75 | -0.82 | Upgrade
|
Shareholders' Equity | -0.97 | 0.61 | 15.94 | 37.69 | 33.26 | 11.7 | Upgrade
|
Total Liabilities & Equity | 5.38 | 8.81 | 28.05 | 43.14 | 36.8 | 15.31 | Upgrade
|
Total Debt | - | 0.04 | 0.11 | 0.03 | 1.06 | 1.19 | Upgrade
|
Net Cash (Debt) | 2.98 | 3.34 | 18.24 | 36.53 | 32.35 | 10.69 | Upgrade
|
Net Cash Growth | -49.39% | -81.68% | -50.07% | 12.92% | 202.50% | -38.91% | Upgrade
|
Net Cash Per Share | 1.65 | 3.93 | 24.31 | 61.39 | 133.55 | 196.56 | Upgrade
|
Filing Date Shares Outstanding | 1.81 | 1.32 | 0.84 | 0.67 | 0.47 | 0.06 | Upgrade
|
Total Common Shares Outstanding | 1.81 | 1.06 | 0.84 | 0.67 | 0.42 | 0.06 | Upgrade
|
Working Capital | -1.44 | -0.72 | 16.9 | 35.53 | 32.98 | 11.6 | Upgrade
|
Book Value Per Share | -0.54 | 0.57 | 19.07 | 56.58 | 79.86 | 204.02 | Upgrade
|
Tangible Book Value | -0.97 | 0.61 | 15.94 | 37.69 | 33.26 | 11.7 | Upgrade
|
Tangible Book Value Per Share | -0.54 | 0.57 | 19.07 | 56.58 | 79.86 | 204.02 | Upgrade
|
Machinery | - | 0.42 | 0.41 | 0.42 | 0.58 | 5.46 | Upgrade
|
Leasehold Improvements | - | 0.01 | 0.01 | 0.01 | 0.41 | 0.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.